Submission of Outcome of Board Meeting held on May, 19 2026 as per Reg.30 of SEBI LODR 2015
SHAILY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts more than Nifty Microcap 250 and 1.9 pts more than its Plastic Products - Consumer peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shaily Engineering Plastics reported strong FY26 audited results. Standalone revenue grew 23.6% to Rs. 92,120 lakhs while consolidated revenue rose 25.9% to Rs. 99,067 lakhs. Net profit more than doubled on standalone basis to Rs. 16,132 lakhs (up 127% YoY) and consolidated PAT jumped 82.5% to Rs. 16,991 lakhs. The Board recommended a final dividend of Rs. 3 per share (150% on Rs. 2 face value). An enabling resolution was passed for raising up to Rs. 500 crores to fund expansion into healthcare drug delivery devices, consumer electronics, and semiconductor components (including a supply agreement with a Korean firm). Mr. Chi Hung Kam was appointed as COO - Healthcare (KMP) effective May 20, 2026. New internal and cost auditors were appointed for FY27.
The company delivered exceptional profit growth exceeding 100% on standalone and 82% on consolidated basis, signaling strong execution. The Rs. 500 crore fund raise enables diversification into high-growth adjacent sectors, reducing reliance on traditional precision plastics. Fresh appointment of an experienced healthcare manufacturing leader strengthens execution capability for new verticals.